eClinical news in brief

By staff reporter

- Last updated on GMT

Related tags Medidata rave Clinical trial Interactive voice response

Outsourcing-Pharma tracks the latest eClinical movements, featuring
Medidata, Clinphone, Phlexglobal and Octagon Research Solutions.

This week it was announced that Wyeth Pharmaceuticals has elected to exclusively use Medidata's Rave electronic data capture (EDC) system across its company after deciding to stop using its own in-house EDC system. "The deployment of EDC technology has been an extremely important initiative at Wyeth - in the past 11 months, we have increased the rate of EDC usage in trials to more than 90 percent,"​ said Ira Spector, vice president of Clinical Development Operations at Wyeth Research. The firm said it plans to conduct several hundred global studies using Medidata Rave during a seven-year term, with the first trial beginning in the first quarter of 2008. Other new business gains the firm has had of late include a multi-year contract with Copenhagen-based pharmaceutical firm H. Lundbeck to manage more than 10 psychiatric phase II-IV trials, using its latest version of Medidata Rave, version 5.6. Recently, Medidata also announced the commencement of a new partnership with EPS, one of Japan's largest contract research organisations (CRO), who will now incorporate Medidata Rave into their existing offerings. In Japan, rival eclinical firm ClinPhone has also recently inked a deal, this time with Bayer's Japanese arm, Bayer Yakuhin. ClinPhone said it will be Bayer's preferred supplier of randomisation and trial supply management services, specifically using its interactive voice response system (IVRS) for a Japanese phase III trial. Phlexglobal has launched what it calls a "unique"​ electronic trial master file (TMF) solution - PhlexEview, which it says allows electronic searching and viewing of TMF documentation from sponsors, subsidiaries, CROs and field-based personnel. "Documentation is centralised from the start of a clinical trial and available for viewing from anywhere at anytime, avoiding the common end of study TMF reconciliation difficulties,"​ said the firm. Meanwhile, Octagon Research Solutions has opened a new office in Mountain View, California, in order to establish a West Coast presence and "draw from the strong Silicon Valley talent pool."

Related news

Show more

Related products

show more

SDTM supplemental qualifiers explained

SDTM supplemental qualifiers explained

Content provided by Formedix | 12-May-2023 | White Paper

What are SDTM supplemental qualifiers? In short, these are variables in non-CDISC datasets that cannot be mapped to a variable that matches the SDTM standard....

How clinical trial software can optimize trials

How clinical trial software can optimize trials

Content provided by Formedix | 17-Apr-2023 | White Paper

Companies often have to conduct multiple clinical trials at the same time, which means they've got to be efficient, and compliant with industry regulations....

4 Warning Signs Your Research Site Is in Trouble

4 Warning Signs Your Research Site Is in Trouble

Content provided by Elligo Health Research® | 13-Apr-2023 | Insight Guide

You want your clinical research practice to be a success for your business and your patients, but how can you tell if it’s in trouble? Read this article...

ODM and CDASH in CRF design

ODM and CDASH in CRF design

Content provided by Formedix | 10-Mar-2023 | White Paper

The lesser-known Operational Data Model (ODM) standard is often overlooked as it's not required by any regulators. So, why should you be interested...

Related suppliers

Follow us


View more